-
Recently:
Recent Tweets
- Johnson & Johnson Fined 1.2 Billion in Risperdal Drug Case manicmuses.wordpress.com/2012/04/12/j-j… 1 month ago
- Does a Bipolar Mind Encourage Creative Genius? manicmuses.wordpress.com/2012/04/03/doe… 2 months ago
- Terminated Employee with Bipolar Disorder Awarded $315,000 in ADA Case tinyurl.com/76nkacs 2 months ago
- AstraZeneca wins bipolar disorder drug patent case for Seroquel XR tinyurl.com/6wnxf2s 2 months ago
- US Court Dismisses Astrazeneca Seroquel Suit tinyurl.com/cg7g7fy 2 months ago
Tags
abilify Ambien Anxiety disorder Aripiprazole Atorvastatin bipolar Bipolar disorder Bipolar II disorder Bupropion Canada Centre for Addiction and Mental Health Clonazepam Clopidogrel Generic drug Health Hypomania Mental disorder Mental Health Mood National Institute of Mental Health Olanzapine Quetiapine Substance abuse Support group ZolpidemCopyright
© Manic Muses - Vivien Brunning. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Vivien Brunning and Manic Muses with appropriate and specific direction to the original content.
Monthly Archives: October 2011
Should Involuntary Treatment for the Mentally Ill Be the Law?
Before I make my exit for the month of November to take part in NaNoWriMo, let me leave you with something meaty to chew on while I’m offline. In 2002, California passed legislation allowing judges to order involuntary treatment for … Continue reading
Posted in Family Support, Health Care Costs, Hospitlization, Mental Illness, Stigma
9 Comments
More on Bipolar and Socioeconomic Status
Genes can be reset during early life in profoundly different ways depending on whether children grow up in privileged or deprived households, a landmark study has shown. The penalty might be activation of genes that make poorer people more prone … Continue reading
Posted in Bipolar, Manic-depression, Mental Illness, Socioeconomic
Leave a comment
FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
SILVER SPRING, Md., Oct. 24, 2011 — /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder. Read the … Continue reading
Researchers at the University of Leeds investigating the genetic causes of bipolar disorder have identified two new drugs – one of which has already been found safe in clinical trials – that may be effective in treating the disorder.
Researchers at the University of Leeds investigating the genetic causes of bipolar disorder have identified two new drugs – one of which has already been found safe in clinical trials – that may be effective in treating the disorder. Read … Continue reading
Hypomania or Mania – Which was it?
I’ve had this post in the hopper for a while, and finally decided to publish it after reading another blogger’s post today about what she believes are the differences between Bipolar I and Bipolar II. Basically, I believe she is … Continue reading
Posted in Uncategorized
16 Comments
SK biopharmaceuticals Enters into a Licensing Agreement with Premier Chinese Biopharmaceutical Company
SEOUL, Korea, Oct 19, 2011 (BUSINESS WIRE) — South Korean biotech SK biopharmaceuticals announced yesterday that they entered into a research and development agreement with Medicilon, of Shanghai, China, for their novel new small molecule SKL-PSY that is being developed … Continue reading
Posted in Bipolar, Manic-depression, Medication - Mental Illness
7 Comments
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Forest Laboratories, Inc. FRX +0.94% and Gedeon Richter Plc today announced preliminary top-line results from a Phase III clinical trial of cariprazine (RGH-188), an investigational antipsychotic agent, in patients with acute mania associated with bipolar I disorder. Cariprazine is also … Continue reading
October 2-8 is Mental Illness Awareness Week
While the US has its share of legitimate health crises, none is as widespread or contributes as much to the burden of illness as do mental illnesses. With October 2-8 being Mental Illness Awareness Week, it’s an ideal time to … Continue reading
Posted in Mental Illness
9 Comments


